Suchergebnisse - "Sexton, Wade J"

PubPharm (253)

1

Reply to Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al's Letter to the Editor re : E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266-274

enthalten in: European urology oncology | 2024

von Abel, E. | Master, V. | Spiess, P. | +9

2

The Selection for Cytoreductive Nephrectomy (SCREEN) Score : Improving Surgical Risk Stratification by Integrating Common Radiographic Features

enthalten in: European urology oncology | 2024

von Abel, E. | Master, V. | Spiess, P. | +9

3

Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial Carcinoma

enthalten in: European urology | 2024

von Huelster, H. | Gould, B. | Schiftan, E. | +18

4

Editorial Comment

enthalten in: The Journal of urology | 2024

von Linscott, J. | Sexton, W.

CommentOn: J Urol. 2024 Apr;211(4):564-574. - PMID 38153961

5

Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer

enthalten in: European urology oncology | 2024

von Li, R. | Nocera, L. | Rose, K. | +15

6

First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumors

enthalten in: Urologic oncology | 2024

von Jacob, J. | Woldu, S. | Linehan, J. | +18

7

Re : Wesley Yip, Alireza Ghoreifi, Thomas Gerald, et al. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. Eur Urol. Onc. 2023;604-610

enthalten in: European urology oncology | 2023

von Shapiro, D. | Karam, J. | Master, V. | +4

CommentOn: Eur Urol Oncol. 2023 Dec;6(6):604-610. - PMID 37005212

8

Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Antonelli, L. | Ardizzone, D. | Tachibana, I. | +29

9

Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy : A Multi-institutional Analysis of 1272 Consecutive Patients

enthalten in: Urology | 2023

von Esdaille, A. | Karam, J. | Master, V. | +12

10

Primary Chemoablation for Intermediate-risk Low-grade Bladder Cancer : New Paradigm or Added Uncertainty?

enthalten in: The Journal of urology | 2023

von Murthy, P. | Sexton, W.

CommentIn: J Urol. 2023 Dec;210(6):840. - PMID 37769639

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]